Stiripentol, a putative antiepileptic drug, enhances the duration of opening of GABA-A receptor channels
about
Stiripentol for focal refractory epilepsyAntiepileptic drugs for the treatment of infants with severe myoclonic epilepsyAntiepileptic drugs for the treatment of severe myoclonic epilepsy in infancyStiripentol for focal refractory epilepsyStiripentol for focal refractory epilepsyAntiepileptic drugs for the treatment of severe myoclonic epilepsy in infancyThe anti-convulsant stiripentol acts directly on the GABA(A) receptor as a positive allosteric modulatorLow-dose fenfluramine in the treatment of neurologic disorders: experience in Dravet syndromeEpilepsy treatment. Targeting LDH enzymes with a stiripentol analog to treat epilepsyMolecular mechanisms of antiseizure drug activity at GABAA receptorsThe pharmacologic treatment of Dravet syndromeSevere myoclonic epilepsy in infancy: a systematic review and a meta-analysis of individual patient data.Stiripentol : in severe myoclonic epilepsy of infancy (dravet syndrome).A Stability-Indicating HPLC-DAD Method for Determination of Stiripentol: Development, Validation, Kinetics, Structure Elucidation and Application to Commercial Dosage FormThe effects of stiripentol on GABA(A) receptorsEmerging drugs for epilepsy.Pharmacotherapy for Dravet Syndrome.Stiripentol.GABA(A) receptors in normal development and seizures: friends or foes?Potentiating the Strength of Extrasynaptic Currents by Neurosteroid Hormones.Audit of use of stiripentol in adults with Dravet syndromeCurrent therapeutic procedures in Dravet syndrome.Drug interactions with the newer antiepileptic drugs (AEDs)--part 1: pharmacokinetic and pharmacodynamic interactions between AEDs.Stiripentol in Dravet syndrome: results of a retrospective U.S. study.Therapeutic approach to epileptic encephalopathies.The GABA synapse as a target for antiepileptic drugs: a historical overview focused on GABA transporters.Stiripentol and vigabatrin current roles in the treatment of epilepsy.Antiepileptic drugs for the treatment of infants with severe myoclonic epilepsy.Stiripentol in the Management of Epilepsy.Clobazam as an adjunctive therapy in treating seizures associated with Lennox-Gastaut syndrome.Interactions between modulators of the GABA(A) receptor: Stiripentol and benzodiazepinesTreatment of Lennox-Gastaut syndrome: overview and recent findings.Neuroprotective activity of stiripentol with a possible involvement of voltage-dependent calcium and sodium channels.Stiripentol for the treatment of super-refractory status epilepticus.Commentary: Targeting LDH enzymes with a stiripentol analog to treat epilepsy.Ethanol selectively attenuates NMDAR-mediated synaptic transmission in the prefrontal cortex.Valnoctamide enhances phasic inhibition: a potential target mechanism for the treatment of benzodiazepine-refractory status epilepticus.Stiripentol in refractory status epilepticus.Early-life febrile seizures worsen adult phenotypes in Scn1a mutants.Characterization of the anticonvulsant, behavioral and pharmacokinetic interaction profiles of stiripentol in combination with clonazepam, ethosuximide, phenobarbital, and valproate using isobolographic analysis.
P2860
Q24186440-115D1E17-54C3-4605-9118-864320A64F04Q24186474-FF389FA4-6534-4359-B6A3-242F88F210EBQ24198031-2FE0EFDA-267C-41E1-8734-22AF4F9186CEQ24198833-1950C330-DB3C-4BD0-B843-B85BA1D8E085Q24200888-1E2B752D-CD84-4F87-A240-45A120FF8742Q24202411-305ADEF0-C0C5-40F8-8D52-A96F52E7BFE0Q24646448-AB4A33B5-1B65-4667-B4E6-F88C0DF28E75Q26776222-3129E9A4-B636-4390-A4DF-AA4D237D40B5Q28259250-155F375A-DAE4-4324-B640-204611CEFB7CQ28681145-CF02ED02-115E-404A-BD71-32D527B5FF1AQ29013852-8A7D6EE7-F301-4410-A2D8-DD4A33058012Q31137269-E23B3ECB-7296-4DAC-A9D7-A57ACC179E33Q34302354-28086463-F47D-49D0-A7E2-504AFB6A29DCQ34412668-97DA5C1A-D775-4DC2-9DC4-F2E2A22316BCQ34660454-69B5D252-12AF-4D8B-820B-CEA1132FF965Q34688725-4D39BB14-88B1-4C15-9D58-046DBB7A1678Q35953476-C012EE7E-D6A2-4371-BEFC-44DAE91869ADQ36697489-16572F7E-31E7-477E-B63D-A0804640E828Q37104140-E2E363CA-1262-4DA3-9171-E76E305F1094Q37182457-F9DC9039-203C-4CCC-B2EF-AC1E75C099C6Q37505426-95EF9A6A-2224-4240-976F-169066977B4FQ37866832-E2372B96-445A-41D4-B18F-127D25D55174Q38115721-41A62023-03E0-412F-8EB7-28111D5F2B40Q38121171-D3C957E9-D261-42F3-93CC-951423AFB604Q38191250-239D5C0A-A552-41EB-A38B-E4979A0544A9Q38195817-487A5B64-7E72-426B-BFA1-51EBEB1E7614Q38757727-38C59415-665E-4775-A844-1188A3E151E1Q38776903-B7E383DF-AF5A-42B3-A060-9A89351EA27FQ39256887-A1233120-55B0-4074-A183-547D9B44C744Q39416423-77FCA8E8-85D8-487E-8691-47FAEBA3EC9CQ39607659-86CF257C-272E-4C7D-AB52-6D65CF62B9F1Q39990727-1C91BFEC-6375-4269-A340-B678D1F51FACQ40382329-22080252-E2F6-419F-B479-AA3FB56A857DQ41159617-10D4A723-042D-428A-8958-EB358CE77646Q41336182-9B4E8E8D-CF95-4BF1-9261-C4D9C92CF6DFQ41653437-D9EEC773-8A14-4C03-BDB2-B525F4FA2103Q42077761-B405588F-2055-43E4-B52A-5B3EBDC89DD8Q45758314-86396159-A52C-4DAE-B118-3075DD64784EQ46005355-7F982F82-09E6-4B77-9C58-D7F1B909974FQ48364123-44608BBA-1511-4F84-9071-D971EB1B687D
P2860
Stiripentol, a putative antiepileptic drug, enhances the duration of opening of GABA-A receptor channels
description
2006 nî lūn-bûn
@nan
2006 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Stiripentol, a putative antiep ...... ng of GABA-A receptor channels
@ast
Stiripentol, a putative antiep ...... ng of GABA-A receptor channels
@en
Stiripentol, a putative antiep ...... ng of GABA-A receptor channels
@nl
type
label
Stiripentol, a putative antiep ...... ng of GABA-A receptor channels
@ast
Stiripentol, a putative antiep ...... ng of GABA-A receptor channels
@en
Stiripentol, a putative antiep ...... ng of GABA-A receptor channels
@nl
prefLabel
Stiripentol, a putative antiep ...... ng of GABA-A receptor channels
@ast
Stiripentol, a putative antiep ...... ng of GABA-A receptor channels
@en
Stiripentol, a putative antiep ...... ng of GABA-A receptor channels
@nl
P2093
P2860
P3181
P1433
P1476
Stiripentol, a putative antiep ...... ng of GABA-A receptor channels
@en
P2093
Catherine Chiron
Henri Gozlan
Pascale P Quilichini
Yehezkel Ben-Ari
P2860
P304
P3181
P356
10.1111/J.1528-1167.2006.00497.X
P407
P577
2006-04-01T00:00:00Z